Armistice Capital »

Nuwellis shares owned by Armistice Capital

Quarter-by-quarter ownership of Nuwellis (NUWE) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Nuwellis

Tip: Access up to 7 years of quarterly data

All positions including Nuwellis held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nuwellis by Armistice Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $248k 236k 1.05

More positions owned by Armistice Capital

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Agios Pharmaceuticals (AGIO)
Cytokinetics Com New (CYTK)
Ptc Therapeutics I (PTCT)
Travere Therapeutics (TVTX)
Madrigal Pharmaceuticals (MDGL)
Immunovant (IMVT)
Supernus Pharmaceuticals (SUPN)
Neurocrine Biosciences (NBIX)
Freshpet (FRPT)
Incyte Corporation (INCY)
Dyne Therapeutics (DYN)
Amazon (AMZN)
Ironwood Pharmaceuticals Com Cl A (IRWD)

View all positions for Armistice Capital

Top funds holding Nuwellis

Armistice Capital
Sabby Management
Geode Capital Management
XTX Topco
Citigroup
Tower Research Capital
SBI Securities
UBS Group
Caitong International Asset Management
Ankerstar Wealth

View all funds holding Nuwellis